REVB Latest Press Releases

-- November 5, 2026 --

Revelation Biosciences, Inc. Announces Financial Results For the Three and Nine Months Ended September 30, 2026 Business Wire 5:29 PM

-- October 16, 2026 --

Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026 Business Wire 9:00 AM

-- August 19, 2026 --

Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study Business Wire 9:00 AM

-- August 6, 2026 --

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026 ACCESS Newswire 4:15 PM

-- August 3, 2026 --

Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury ACCESS Newswire 9:00 AM

-- July 21, 2026 --

Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ACCESS Newswire 4:05 PM

-- July 10, 2026 --

Revelation Biosciences Announces Adoption of Stockholder Rights Plan ACCESS Newswire 4:05 PM

Market Data Delayed 15 Minutes